Fundraising Fox
/Companies
Sign in

Medzown

Founded 2022 · 39 employees on LinkedIn · 2 known investors

Find your way into Medzown

Sign up to see every warm intro you have to Medzown

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Medzown team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Precision medicine management aligning payer and pharmaceutical incentives around patients with complex oncology and rare diseases.

Investors · 2

Service Provider Capitallisted by Service Provider CapitalVail

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

ImmunomeImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.

Companies working in the same space as Medzown.

Frequently asked questions

What does Medzown do?
Precision medicine management aligning payer and pharmaceutical incentives around patients with complex oncology and rare diseases.
Who are Medzown's investors?
Medzown's investors include GOVO Venture Partners, Service Provider Capital.